Physician profile
Douglas Alan Wright
NPI 1376644708
$9,230.42
in general payments reported to CMS, 2019-2025
58 companies · $2,334 in 2025
The $2,334 reported for 2025 was more than what 75% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71.41 · 2020: $55.41 · 2021: $79.19 · 2022: $1,761 · 2023: $2,324 · 2024: $2,605 · 2025: $2,334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,263.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $1,516.94 | 2019-2025 | Briviact, Nayzilam, Rystiggo |
| Lundbeck LLC | $663.77 | 2022-2025 | Vyepti |
| Abbvie INC. | $615.13 | 2022-2025 | Qulipta, Ubrelvy |
| Biogen, INC. | $539.38 | 2021-2025 | Vumerity, Tysabri, Skyclarys |
| Pfizer INC. | $510.31 | 2023-2025 | |
| Neurocrine Biosciences, INC. | $506.07 | 2022-2025 | Ingrezza, Ongentys |
| Argenx US, INC. | $477.75 | 2022-2025 | Vyvgart, Vyvgart Hytrulo |
| Alexion Pharmaceuticals, INC. | $414.33 | 2022-2025 | Ultomiris, Soliris |
| Tg Therapeutics, INC. | $386.36 | 2023-2025 | |
| Amgen INC. | $332.12 | 2021-2025 | Aimovig, Uplizna |
| Impel Pharmaceuticals INC. | $315.58 | 2022-2023 | Trudhesa |
| Lilly USA, LLC | $237.40 | 2022-2025 | Emgality, Reyvow, Kisunla |
| Mdd US Operations, LLC | $212.82 | 2022-2025 | Xadago, Apokyn, Apokyn |
| Genzyme Corporation | $162.12 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $134.38 | 2020-2025 |
Show all 58 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.